Meristem Family Wealth, LLC Danaher Corp Transaction History

Meristem Family Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $1.12 Million - $6.85 Million	-4,544 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$257.27 - $315.76 $55,570 - $68,204	-216 Reduced 4.54%	4,544 $1.33 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $290,992 - $355,367	1,069 Added 28.96%	4,760 $1.45 Million
Q2 2021 Aug 06, 2021	BUY	$225.08 - $271.69 $348,648 - $420,847	1,549 Added 72.32%	3,691 $991,000
Q1 2021 May 12, 2021	BUY	$212.38 - $245.9 $90,898 - $105,245	428 Added 24.97%	2,142 $482,000
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $72,250 - $83,456	340 Added 24.75%	1,714 $381,000
Q3 2020 Nov 13, 2020	BUY	$177.16 - $215.33 $243,417 - $295,863	1,374 New	1,374 $296,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.